67 related articles for article (PubMed ID: 38628740)
1. LINC01589 serves as a potential tumor-suppressor and immune-related biomarker in endometrial cancer: A review.
Chen R; An J; Wang Y; Yang L; Lin Q; Wang Y
Medicine (Baltimore); 2023 Apr; 102(15):e33536. PubMed ID: 37058060
[TBL] [Abstract][Full Text] [Related]
2. Uncovering a novel DNA repair-related radiosensitivity model for evaluation of radiotherapy susceptibility in uterine corpus endometrial cancer.
Yang H; Qiu Y; Chen J; Lai J
Heliyon; 2024 Apr; 10(8):e29401. PubMed ID: 38628740
[TBL] [Abstract][Full Text] [Related]
3. Development and Clinical Validation of Novel 8-Gene Prognostic Signature Associated With the Proportion of Regulatory T Cells by Weighted Gene Co-Expression Network Analysis in Uterine Corpus Endometrial Carcinoma.
Liu J; Geng R; Yang S; Shao F; Zhong Z; Yang M; Ni S; Cai L; Bai J
Front Immunol; 2021; 12():788431. PubMed ID: 34970268
[TBL] [Abstract][Full Text] [Related]
4. A radiosensitivity gene signature and PD-L1 status predict clinical outcome of patients with invasive breast carcinoma in The Cancer Genome Atlas (TCGA) dataset.
Jang BS; Kim IA
Radiother Oncol; 2017 Sep; 124(3):403-410. PubMed ID: 28579282
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a novel DNA damage repair-related long non-coding RNA signature in predicting prognosis, immunity, and drug sensitivity in uterine corpus endometrial carcinoma.
Wang T; Ji M; Liu W; Sun J
Comput Struct Biotechnol J; 2023; 21():4944-4959. PubMed ID: 37876625
[TBL] [Abstract][Full Text] [Related]
6. A radiosensitivity gene signature and PD-L1 predict the clinical outcomes of patients with lower grade glioma in TCGA.
Jang BS; Kim IA
Radiother Oncol; 2018 Aug; 128(2):245-253. PubMed ID: 29784449
[TBL] [Abstract][Full Text] [Related]
7. Integrating Intrinsic Radiosensitivity and Immune Status for Predicting Benefits of Radiotherapy in Head and Neck Squamous Cell Carcinoma.
Sun C; Zhang M; Qiao Q; Wang Y
Med Sci Monit; 2021 Oct; 27():e932126. PubMed ID: 34670999
[TBL] [Abstract][Full Text] [Related]
8. Screening and validation of potential markers associated with uterine corpus endometrial carcinoma and polycystic ovary syndrome based on bioinformatics methods.
Wu R; Wu C; Zhu B; Li J; Zhao W
Front Mol Biosci; 2023; 10():1192313. PubMed ID: 37363398
[No Abstract] [Full Text] [Related]
9. HLA and tumour immunology: immune escape, immunotherapy and immune-related adverse events.
Jiang N; Yu Y; Wu D; Wang S; Fang Y; Miao H; Ma P; Huang H; Zhang M; Zhang Y; Tang Y; Li N
J Cancer Res Clin Oncol; 2023 Feb; 149(2):737-747. PubMed ID: 36662304
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy treatment landscape for patients with endometrial cancer: current evidence and future opportunities.
Hom-Tedla M; Eskander RN
Clin Adv Hematol Oncol; 2023 Jan; 21(1):27-34. PubMed ID: 36638353
[TBL] [Abstract][Full Text] [Related]
11. Radiation Therapy for Endometrial Cancer: An American Society for Radiation Oncology Clinical Practice Guideline.
Harkenrider MM; Abu-Rustum N; Albuquerque K; Bradfield L; Bradley K; Dolinar E; Doll CM; Elshaikh M; Frick MA; Gehrig PA; Han K; Hathout L; Jones E; Klopp A; Mourtada F; Suneja G; Wright AA; Yashar C; Erickson BA
Pract Radiat Oncol; 2023; 13(1):41-65. PubMed ID: 36280107
[TBL] [Abstract][Full Text] [Related]
12. DNA repair inhibitors and radiotherapy.
Monge-Cadet J; Moyal E; Supiot S; Guimas V
Cancer Radiother; 2022 Oct; 26(6-7):947-954. PubMed ID: 35987813
[TBL] [Abstract][Full Text] [Related]
13. Key biological mechanisms involved in high-LET radiation therapies with a focus on DNA damage and repair.
Nikitaki Z; Velalopoulou A; Zanni V; Tremi I; Havaki S; Kokkoris M; Gorgoulis VG; Koumenis C; Georgakilas AG
Expert Rev Mol Med; 2022 Mar; 24():e15. PubMed ID: 35357290
[TBL] [Abstract][Full Text] [Related]
14. Natural Kinase Inhibitors for the Treatment and Management of Endometrial/Uterine Cancer: Preclinical to Clinical Studies.
Singla RK; Behzad S; Khan J; Tsagkaris C; Gautam RK; Goyal R; Chopra H; Shen B
Front Pharmacol; 2022; 13():801733. PubMed ID: 35264951
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
